Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
|
OSI PHARMACEUTICALS INC (OSIP)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Sep-30-04 | Sep-30-03 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 2.1% | 2.5% | 2.8% | 3.6% | 3.6% | -10.1% | 21.0% | 0.5% |
| Gross profit | 97.9% | 97.5% | 97.2% | 96.4% | 96.4% | 110.1% | 79.0% | 99.5% |
| Selling, general and administrative | 24.1% | 25.0% | 29.1% | 44.6% | 64.4% | 164.5% | 231.1% | 217.9% |
| Research and development | 35.5% | 35.7% | 36.2% | 48.8% | 84.3% | 258.5% | 257.9% | 317.1% |
| EBITDA | 40.8% | 39.6% | 35.1% | 17.3% | -31.6% | | -328.5% | |
| Depreciation | 2.3% | 2.8% | 3.1% | 14.2% | 20.7% | | 81.6% | |
| EBITA | 38.4% | 36.8% | 31.9% | 3.1% | -52.4% | -374.9% | -410.0% | -435.5% |
| Amortization of intangibles | 0.2% | 0.7% | 0.5% | 0.8% | 11.0% | 30.8% | 43.5% | 28.7% |
| EBIT | 38.2% | 36.2% | 31.4% | 2.3% | -63.4% | -405.7% | -453.5% | -464.2% |
| Pre-tax income | 31.1% | 31.8% | 29.2% | 2.8% | -61.5% | 0.0% | -608.3% | -560.3% |
| Income taxes | 13.4% | -83.3% | 0.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 17.7% | 116.4% | 17.7% | 2.8% | -113.5% | 0.0% | -608.3% | -560.3% |
|